Pricing
Login
Home
Charts
Search
Watchlist
Products

Evonile Pharma Ltd

EVONILE
₹1,367.60-1.82%20 Nov 2026
Reports
Pharma MNC Bulk Drugs

Evonile Pharma Ltd

EVONILE
₹1,367.60
-1.82%
20 Nov 2026
Ask AI
6M
Price
Charts
Documents

Quick Ratios

Edit Ratios
Mkt Cap
Market Capitalization
₹4,784Cr
Close
Close Price
₹1,367.60
Industry
Industry
Pharma MNC Bulk Drugs
PE
Price To Earnings
—
PS
Price To Sales
14.22
Revenue
Revenue
₹336Cr
Rev Gr TTM
Revenue Growth TTM
-5.20%
PAT Gr TTM
PAT Growth TTM
-103.74%

Quarterly Results

Standalone
Numbers
Percentage
QuarterDec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026
Revenue
RevenueCr
8581928793848890869110456
Growth YoY
Revenue Growth YoY%
5.56.61.910.610.03.3-5.13.7-7.68.018.6-38.0
Expenses
ExpensesCr
657068696760606664706988
Operating Profit
Operating ProfitCr
2011241826242724222135-32
OPM
OPM%
23.413.826.020.627.528.531.126.426.022.833.6-56.8
Other Income
Other IncomeCr
2210101011111199109-61
Interest Expense
Interest ExpenseCr
000000001005
Depreciation
DepreciationCr
001111110004
PBT
PBTCr
4121342835343733303043-101
Tax
TaxCr
1578710510814511-24
PAT
PATCr
2715262025292824162532-78
Growth YoY
PAT Growth YoY%
249.2-41.327.1-13.8-4.299.67.318.7-36.8-13.816.6-420.1
NPM
NPM%
31.418.127.923.427.434.931.626.818.727.931.0-138.3
EPS
EPS₹
9.15.08.87.08.710.09.48.35.58.611.0-26.4
QuarterDec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026
Revenue
RevenueCr
8581928793848890869110456
Growth YoY
Revenue Growth YoY%
5.56.61.910.610.03.3-5.13.7-7.68.018.6-38.0
Expenses
ExpensesCr
657068696760606664706988
Operating Profit
Operating ProfitCr
2011241826242724222135-32
OPM
OPM%
23.413.826.020.627.528.531.126.426.022.833.6-56.8
Other Income
Other IncomeCr
2210101011111199109-61
Interest Expense
Interest ExpenseCr
000000001005
Depreciation
DepreciationCr
001111110004
PBT
PBTCr
4121342835343733303043-101
Tax
TaxCr
1578710510814511-24
PAT
PATCr
2715262025292824162532-78
Growth YoY
PAT Growth YoY%
249.2-41.327.1-13.8-4.299.67.318.7-36.8-13.816.6-420.1
NPM
NPM%
31.418.127.923.427.434.931.626.818.727.931.0-138.3
EPS
EPS₹
9.15.08.87.08.710.09.48.35.58.611.0-26.4

Profit & Loss

Standalone
Numbers
Percentage
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
690656564491438381400379335356354336
Growth
Revenue Growth%
-21.0-4.9-14.1-13.0-10.7-13.04.9-5.3-11.56.3-0.5-5.2
Expenses
ExpensesCr
656631570478426355373314270265260290
Operating Profit
Operating ProfitCr
3425-6121227276565919446
OPM
OPM%
5.03.8-1.12.52.87.06.817.219.525.726.613.7
Other Income
Other IncomeCr
8171172783633-1658624239-33
Interest Expense
Interest ExpenseCr
016268521116
Depreciation
DepreciationCr
343313121063225
PBT
PBTCr
11192158862940-41151231301302
Tax
TaxCr
3935793419190123830366
PAT
PATCr
725778521021-41038510193-4
Growth
PAT Growth%
-8.4-21.137.0-33.9-80.5107.3-117.82,878.5-17.618.4-7.7-103.7
NPM
NPM%
10.58.713.910.62.35.5-0.927.325.428.326.3-1.2
EPS
EPS₹
62.016.123.917.63.47.1-1.335.229.034.431.8-1.4
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
690656564491438381400379335356354336
Growth
Revenue Growth%
-21.0-4.9-14.1-13.0-10.7-13.04.9-5.3-11.56.3-0.5-5.2
Expenses
ExpensesCr
656631570478426355373314270265260290
Operating Profit
Operating ProfitCr
3425-6121227276565919446
OPM
OPM%
5.03.8-1.12.52.87.06.817.219.525.726.613.7
Other Income
Other IncomeCr
8171172783633-1658624239-33
Interest Expense
Interest ExpenseCr
016268521116
Depreciation
DepreciationCr
343313121063225
PBT
PBTCr
11192158862940-41151231301302
Tax
TaxCr
3935793419190123830366
PAT
PATCr
725778521021-41038510193-4
Growth
PAT Growth%
-8.4-21.137.0-33.9-80.5107.3-117.82,878.5-17.618.4-7.7-103.7
NPM
NPM%
10.58.713.910.62.35.5-0.927.325.428.326.3-1.2
EPS
EPS₹
62.016.123.917.63.47.1-1.335.229.034.431.8-1.4
Sales CAGR
1 Year-1%
3 Years-2%
5 Years-1%
TTM-5%
EBITDA CAGR
1 Year3%
3 Years13%
5 Years29%
TTM-54%
PAT CAGR
1 Year-8%
3 Years-3%
5 Years35%
TTM-
Avg. ROCE
1 Year16%
3 Years16%
5 Years13%
TTM1%
CFO / EBITDA
1 Year50%
3 Years94%
5 Years93%
TTM-

Balance Sheet

Standalone
Numbers
Percentage
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Sep 2026
Equity Capital
Equity CapitalCr
161412121212121212121212
Reserves
ReservesCr
1,178906721747708699679763732773805759
Current Liabilities
Current LiabilitiesCr
2041833301852331592161591571421451,208
Non Current Liabilities
Non Current LiabilitiesCr
344747381241324948232115298
Total Liabilities
Total LiabilitiesCr
1,4331,1501,1119821,0781,0029589839259489782,278
Current Assets
Current AssetsCr
1,264973952806813723709677699746768525
Non Current Assets
Non Current AssetsCr
1691771581762652792493062262022101,753
Total Assets
Total AssetsCr
1,4331,1501,1119821,0781,0029589839259489782,278
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Sep 2026
Equity Capital
Equity CapitalCr
161412121212121212121212
Reserves
ReservesCr
1,178906721747708699679763732773805759
Current Liabilities
Current LiabilitiesCr
2041833301852331592161591571421451,208
Non Current Liabilities
Non Current LiabilitiesCr
344747381241324948232115298
Total Liabilities
Total LiabilitiesCr
1,4331,1501,1119821,0781,0029589839259489782,278
Current Assets
Current AssetsCr
1,264973952806813723709677699746768525
Non Current Assets
Non Current AssetsCr
1691771581762652792493062262022101,753
Total Assets
Total AssetsCr
1,4331,1501,1119821,0781,0029589839259489782,278

Cash Flow

Standalone
Financial YearMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
-194-23-6939451137547
Investing Cash Flow
Investing Cash FlowCr
274569587-15333-318
Financing Cash Flow
Financing Cash FlowCr
-30-41-37-36-30-121-64-64
Net Cash Flow
Net Cash FlowCr
50-9-1190-1392670
Free Cash Flow
Free Cash FlowCr
-208-24-6938451137546
CFO To PAT
CFO To PAT%
-375.3-229.6-331.1-1,039.543.3133.173.950.1
CFO To EBITDA
CFO To EBITDA%
-1,582.1-192.3-258.3142.668.8173.881.649.7
Financial YearMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
-194-23-6939451137547
Investing Cash Flow
Investing Cash FlowCr
274569587-15333-318
Financing Cash Flow
Financing Cash FlowCr
-30-41-37-36-30-121-64-64
Net Cash Flow
Net Cash FlowCr
50-9-1190-1392670
Free Cash Flow
Free Cash FlowCr
-208-24-6938451137546
CFO To PAT
CFO To PAT%
-375.3-229.6-331.1-1,039.543.3133.173.950.1
CFO To EBITDA
CFO To EBITDA%
-1,582.1-192.3-258.3142.668.8173.881.649.7

Ratios

Standalone
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
2,0731,9031,5121,6931,2401,3631,4581,3962,5401,9382,3974,784
Price To Earnings
Price To Earnings
10.433.319.332.7123.165.213.529.819.225.7
Price To Sales
Price To Sales
3.02.92.73.52.33.03.03.46.95.06.414.2
Price To Book
Price To Book
1.72.12.12.21.71.92.11.83.42.52.92.9
EV To EBITDA
EV To EBITDA
27.743.4-117.988.060.434.635.613.229.914.218.4115.6
Profitability Ratios
Profitability Ratios
GPM
GPM%
49.546.449.351.349.952.647.543.338.840.741.341.3
OPM
OPM%
5.03.8-1.12.52.87.06.817.219.525.726.613.7
NPM
NPM%
10.58.713.910.62.35.5-0.927.325.428.326.3-1.2
ROCE
ROCE%
9.310.122.211.54.46.20.114.716.516.615.90.5
ROE
ROE%
6.16.210.76.81.42.9-0.513.311.412.811.4-0.5
ROA
ROA%
5.15.07.15.30.92.1-0.410.59.210.79.5-0.2
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
2,0731,9031,5121,6931,2401,3631,4581,3962,5401,9382,3974,784
Price To Earnings
Price To Earnings
10.433.319.332.7123.165.213.529.819.225.7
Price To Sales
Price To Sales
3.02.92.73.52.33.03.03.46.95.06.414.2
Price To Book
Price To Book
1.72.12.12.21.71.92.11.83.42.52.92.9
EV To EBITDA
EV To EBITDA
27.743.4-117.988.060.434.635.613.229.914.218.4115.6
Profitability Ratios
Profitability Ratios
GPM
GPM%
49.546.449.351.349.952.647.543.338.840.741.341.3
OPM
OPM%
5.03.8-1.12.52.87.06.817.219.525.726.613.7
NPM
NPM%
10.58.713.910.62.35.5-0.927.325.428.326.3-1.2
ROCE
ROCE%
9.310.122.211.54.46.20.114.716.516.615.90.5
ROE
ROE%
6.16.210.76.81.42.9-0.513.311.412.811.4-0.5
ROA
ROA%
5.15.07.15.30.92.1-0.410.59.210.79.5-0.2
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Market CapitalizationMkt CapCr46,20717,64015,4199,2787,9287,3844,784
Close PriceClose₹2,727.603,856.006,167.505,589.503,442.403,206.101,367.60
IndustryIndustryPharma MNC Bulk DrugsPharma MNC Bulk DrugsPharma MNC Bulk DrugsPharma MNC Bulk DrugsPharma MNC Bulk DrugsPharma MNC Bulk DrugsPharma MNC Bulk Drugs
Price To EarningsPE40.8520.5386.7624.4328.3520.26
Price To SalesPS11.116.655.936.228.104.0514.22
RevenueRevenueCr4,1592,6542,6021,4919791,822336
Revenue Growth TTMRev Gr TTM%12.1%11.8%29.7%16.1%22.7%-5.7%-5.2%
PAT Growth TTMPAT Gr TTM%20.0%2.4%-10.8%23.8%28.4%2.3%-103.7%
Market CapitalizationMkt CapCr46,20717,64015,4199,2787,9287,3844,784
Close PriceClose₹2,727.603,856.006,167.505,589.503,442.403,206.101,367.60
IndustryIndustryPharma MNC Bulk DrugsPharma MNC Bulk DrugsPharma MNC Bulk DrugsPharma MNC Bulk DrugsPharma MNC Bulk DrugsPharma MNC Bulk DrugsPharma MNC Bulk Drugs
Price To EarningsPE40.8520.5386.7624.4328.3520.26
Price To SalesPS11.116.655.936.228.104.0514.22
RevenueRevenueCr4,1592,6542,6021,4919791,822336
Revenue Growth TTMRev Gr TTM%12.1%11.8%29.7%16.1%22.7%-5.7%-5.2%
PAT Growth TTMPAT Gr TTM%20.0%2.4%-10.8%23.8%28.4%2.3%-103.7%
Annual Reports
FY2026
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
Quarterly Reports
FY2026
Mar 26
Result
PPT
Transcript
Summary
Dec 25
Result
PPT
Transcript
Summary
Sep 25
Result
PPT
Transcript
Summary
Mar 25
Result
PPT
Transcript
Summary
Dec 24
Result
PPT
Transcript
Summary
Sep 24
Result
PPT
Transcript
Summary
Jun 24
Result
PPT
Transcript
Summary
Mar 24
Result
PPT
Transcript
Summary
Dec 23
Result
PPT
Transcript
Summary
Sep 23
Result
PPT
Transcript
Summary
Jun 23
Result
PPT
Transcript
Summary
Mar 23
Result
PPT
Transcript
Summary
Dec 22
Result
PPT
Transcript
Summary
Jun 22
Result
PPT
Transcript
Summary
Mar 22
Result
PPT
Transcript
Summary
Dec 21
Result
PPT
Transcript
Summary
Sep 21
Result
PPT
Transcript
Summary
Jun 21
Result
PPT
Transcript
Summary
Sep 20
Result
PPT
Transcript
Summary
Jun 20
Result
PPT
Transcript
Summary
Annual Reports
Quarterly Reports
Mar 26
Result
PPT
Transcript
Summary
Dec 25
Result
PPT
Transcript
Summary
Sep 25
Result
PPT
Transcript
Summary
Mar 25
Result
PPT
Transcript
Summary
Dec 24
Result
PPT
Transcript
Summary
Sep 24
Result
PPT
Transcript
Summary
Jun 24
Result
PPT
Transcript
Summary
Mar 24
Result
PPT
Transcript
Summary
Dec 23
Result
PPT
Transcript
Summary
Sep 23
Result
PPT
Transcript
Summary
Jun 23
Result
PPT
Transcript
Summary
Mar 23
Result
PPT
Transcript
Summary
Dec 22
Result
PPT
Transcript
Summary
Jun 22
Result
PPT
Transcript
Summary
Mar 22
Result
PPT
Transcript
Summary
Dec 21
Result
PPT
Transcript
Summary
Sep 21
Result
PPT
Transcript
Summary
Jun 21
Result
PPT
Transcript
Summary
Sep 20
Result
PPT
Transcript
Summary
Jun 20
Result
PPT
Transcript
Summary
Load More
Interviews